Determining which draining method is best for Plural effusion - Wesley Research Institute
Wesley Research Institute

This one year research project aims to compare two commonly used methods of draining the effusion to determine which one is best.

Research Objectives





Patient Group

Pleural Effusion

Study location

Wesley Research Institute

Study type

Investigator Initiated
find out if you’re eligible

Lead investigators

  • Dr Luke Garske

Clinical Trial Coordinator

  • Chris Henderson
  • Linda Pearce

Technical title

AMPLE-3: A Randomised Study Comparing Combined Indwelling Pleural Catheter (IPC) and Talc Pleurodesis with Video-Assisted Thoracoscopic Surgery (VATS) for the Management of Patients with Malignant Pleural Effusion

About this research project

The lung is covered by a thin lining which produces a very small amount of fluid to lubricate the lungs during breathing. Cancers can spread to this lining causing a build-up of fluid. This is called a malignant pleural effusion. The increased fluid can compress the lungs causing breathlessness. Draining the fluid can ease symptoms but it usually rapidly re-accumulates and needs further drainages.

This one year research project aims to compare two commonly used methods of draining the effusion to determine which one is best. One method involves a surgical procedure (VATS) and the other involves insertion of a long-term flexible chest tube (IPC). IPC and surgical pleurodesis are known to be safe procedures and are both commonly used; however, no one knows if one is better than the other at preventing the fluid from returning and further procedures being required.


Latest News

Lung Cancer METASPATIAL Study awarded $1 million by the Australian Government

We’re delighted to announce that Dr Arutha Kulasinghe is leading the Lung Cancer METASPATIAL Study that has been awarded nearly $1m by the Australian Government. The project is supported by the Wesley Research Institute and the University of Queensland. The METASPATIAL Study will be undertaken over the next 4 years at Wesley Research Institute’s new Queensland Spatial Biology Centre (QSBC).

Lung Cancer Survivor Michel Itel an advocate for Spatial Mapping of Digital Pathology

As a patient with a specific EGFR positive mutation, Michel benefited from targeted therapy, an approach that the new Queensland Spatial Biology Centre (QSBC) aims to enhance for future patients.

Amanda’s Story

Flashback to the middle of 2019, it was just like any other normal day at work for Amanda, until she noticed a lump in her groin.
1 2 3 8
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram